Manualized cognitive behavioral group therapy to treat vasomotor symptoms for women diagnosed with mood disorders.


Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 06 2019
revised: 16 11 2019
accepted: 19 11 2019
pubmed: 15 12 2019
medline: 5 8 2020
entrez: 15 12 2019
Statut: ppublish

Résumé

This 6-week, prospective, single-arm study examined the feasibility, acceptability, and preliminary efficacy of cognitive behavioral group therapy in peri- and postmenopausal women with mood disorders (major depression or bipolar) and problematic vasomotor menopausal symptoms. 59 participants from an outpatient clinic with mood disorders and problematic vasomotor symptoms were enrolled. The primary outcomes were change from baseline to 6 weeks in Hot Flush Night Sweat Problem Rating, Hot Flash Related Daily Interference, and Quality of Life. Secondary outcomes were change in Hot Flush Frequency, depression, anxiety, perceived stress, anhedonia, beliefs and cognitive appraisals of menopause. ClinicalTrials.gov [identifier: NCT02860910]. On the Hot Flush Night Sweat Problem Rating, 39.3% improved 2 or more points, which was clinically relevant. Changes in Quality of Life (p = .001) and the Hot Flash Related Daily Interference Scale were also significant (p < .001). Significant results were found on most secondary outcomes (hot flush frequency on the Hot Flush Daily Diary, depression, anxiety, perceived stress (p < .001) and anhedonia (p = .001). One of six subscales (control subscale) on the cognitive appraisal of menopause significantly improved (p < .001). Three subscales on the beliefs measure did not change significantly (p = .05, p = .91, and p = .14). Six-week study retention was robust (N = 55, 93%) and 94.2% of individuals reported that cognitive behavioral group therapy sessions were useful. This exploratory study suggests that CBGT is acceptable, feasible, and efficacious in women with mood disorders and problematic menopause vasomotor symptoms. Further studies are needed using more rigorous and controlled methods.

Identifiants

pubmed: 31837624
pii: S0022-3999(19)30590-2
doi: 10.1016/j.jpsychores.2019.109882
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02860910']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109882

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Danette Y Conklin (DY)

Department of Psychiatry and Reproductive Biology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address: Danette.Conklin@UHhospitals.org.

Toyomi Goto (T)

Center for Value-based Care Research, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: gotot@ccf.org.

Stephen Ganocy (S)

Case Western Reserve University, Cleveland, OH, USA. Electronic address: sjg18@case.edu.

Sana Loue (S)

Departments of Bioethics, Epidemiology and Biostatics, Psychiatry, and Global Health, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: sxl54@case.edu.

Christine LaGrotta (C)

Icahn School of Medicine at Mount Sinai, Mount Sinai-SLW, New York, NY, USA. Electronic address: Christine.lagrotta@va.gov.

Sarah Delozier (S)

Clinical Research Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address: Sarah.Delozier@UHhospitals.org.

Brittany Brownrigg (B)

Mood Disorders Research Program, University Hospitals Cleveland Medical Center, Department of Psychiatry, Cleveland, OH, USA. Electronic address: Brittany.Brownrigg@UHhospitals.org.

Carla Conroy (C)

Mood Disorders Program, Intervention and Services Research Center, University Hospitals Cleveland Medical Center, Department of Psychiatry, Cleveland, OH, USA. Electronic address: Carla.Conroy@UHhospitals.org.

Nicole D'Arcangelo (N)

University Hospitals Cleveland Medical Center, Department of Psychiatry, Cleveland, OH, USA. Electronic address: nicole.darcangelo@averydennison.com.

Jessica Janes (J)

Clinical Research Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address: Jessica.Janes@UHhospitals.org.

Daisy Ogede (D)

Case Western Reserve University, Cleveland, OH, USA. Electronic address: doo6@case.edu.

Martha Sajatovic (M)

Department of Psychiatry, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address: Martha.Sajatovic@UHhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH